The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126433191 12643319 1 I 201607 20160727 20160811 20160811 EXP US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-121225 RANBAXY 77.61 YR F Y 0.00000 20160811 PH US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126433191 12643319 1 PS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Oral 3 DF, DAILY N 65061 3 DF CAPSULE
126433191 12643319 2 C Adavir Diskus 2 Respiratory (inhalation) 1 PUFF, BID ( IN MORNING + EVENING) U 0 Q12H
126433191 12643319 3 C Carvediol CARVEDILOL 1 Oral 1 DF, BID U 0 1 DF TABLET Q12H
126433191 12643319 4 C CLARITIN LORATADINE 1 Oral 1 DF, QD U 0 1 DF TABLET
126433191 12643319 5 C Cymbalata 2 Oral 1 DF, QD U 0 1 DF
126433191 12643319 6 C GABAPENTIN. GABAPENTIN 1 Oral 1 DF, QD U 0 1 DF CAPSULE
126433191 12643319 7 C HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 Oral 1 DF, BID U 0 1 DF TABLET Q12H
126433191 12643319 8 C ISOSORBIDE MONONITRATE. ISOSORBIDE MONONITRATE 1 Oral 1 DF, QD U 0 1 DF PROLONGED-RELEASE TABLET
126433191 12643319 9 C JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral 2 DF, DAILY U 0 2 DF TABLET
126433191 12643319 10 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 1 DF, QD U 0 1 DF TABLET
126433191 12643319 11 C LIDOCAINE. LIDOCAINE 1 Topical UNK UNK, TID U 0 OINTMENT Q8H
126433191 12643319 12 C LINZESS LINACLOTIDE 1 Oral 1 DF, QD U 0 1 DF CAPSULE
126433191 12643319 13 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 1 DF, BID U 0 1 DF TABLET Q12H
126433191 12643319 14 C NITROGLYCERIN. NITROGLYCERIN 1 Sublingual UNK, PRN U 0 SUBLINGUAL TABLET
126433191 12643319 15 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 1 DF, QD U 0 1 DF CAPSULE
126433191 12643319 16 C PLAVIX CLOPIDOGREL BISULFATE 1 Oral 1 DF, QD U 0 1 DF TABLET
126433191 12643319 17 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Nasal 1 DF, QD ( INHALE 1CAPSULE BY INHALATION ROUTE) U 0 1 DF CAPSULE
126433191 12643319 18 C TYLENOL ACETAMINOPHEN 1 Oral 2 DF, PRN( 2 DF EVERY 8 HOURS AS NEEDED) U 0 2 DF PROLONGED-RELEASE TABLET
126433191 12643319 19 C VALSARTAN. VALSARTAN 1 Oral 1 DF, QD U U 0 1 DF TABLET
126433191 12643319 20 C VESICARE SOLIFENACIN SUCCINATE 1 Oral 1 DF, QD U 0 1 DF TABLET
126433191 12643319 21 C VITAMIN D2 ERGOCALCIFEROL 1 Oral 1 DF, 1/WEEK U 0 1 DF CAPSULE /wk
126433191 12643319 22 C VYTORIN EZETIMIBESIMVASTATIN 1 Oral 1 DF, QD U 0 1 DF TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126433191 12643319 1 Product used for unknown indication
126433191 12643319 2 Product used for unknown indication
126433191 12643319 3 Product used for unknown indication
126433191 12643319 4 Product used for unknown indication
126433191 12643319 5 Product used for unknown indication
126433191 12643319 6 Product used for unknown indication
126433191 12643319 7 Product used for unknown indication
126433191 12643319 8 Product used for unknown indication
126433191 12643319 9 Product used for unknown indication
126433191 12643319 10 Product used for unknown indication
126433191 12643319 11 Product used for unknown indication
126433191 12643319 12 Product used for unknown indication
126433191 12643319 13 Product used for unknown indication
126433191 12643319 14 Myocardial infarction
126433191 12643319 15 Product used for unknown indication
126433191 12643319 16 Product used for unknown indication
126433191 12643319 17 Product used for unknown indication
126433191 12643319 18 Product used for unknown indication
126433191 12643319 19 Product used for unknown indication
126433191 12643319 20 Product used for unknown indication
126433191 12643319 21 Product used for unknown indication
126433191 12643319 22 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126433191 12643319 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126433191 12643319 Dysarthria
126433191 12643319 Dysphonia
126433191 12643319 Dyspnoea
126433191 12643319 Fatigue
126433191 12643319 Foreign body
126433191 12643319 Haemorrhage
126433191 12643319 Product physical issue
126433191 12643319 Productive cough
126433191 12643319 Pyrexia
126433191 12643319 Throat irritation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126433191 12643319 1 2016 201607 0
126433191 12643319 2 20160502 0
126433191 12643319 3 20130807 0
126433191 12643319 4 20151030 0
126433191 12643319 5 20130807 0
126433191 12643319 6 20130807 0
126433191 12643319 7 20130807 0
126433191 12643319 8 20160331 0
126433191 12643319 9 20160309 0
126433191 12643319 10 20160607 0
126433191 12643319 11 20150717 0
126433191 12643319 12 20160304 0
126433191 12643319 13 20160309 0
126433191 12643319 14 20160126 0
126433191 12643319 15 20160407 0
126433191 12643319 16 20160302 0
126433191 12643319 17 20160309 0
126433191 12643319 18 20160106 0
126433191 12643319 19 20151111 0
126433191 12643319 20 20160309 0
126433191 12643319 21 20160418 0
126433191 12643319 22 20130807 0